About Dhanuka Laboratories
Dhanuka Laboratories is a company based in Gurugram (India) founded in 1998 by Ram Gopal Agarwal. Dhanuka Laboratories has raised $7.47 million across 2 funding rounds from investors including Triveni Memorial Educational Trust, Manish Dhanuka and Arun Kumar Dhanuka. The company has 583 employees as of April 04, 2024. Dhanuka Laboratories has completed 1 acquisition, including Orchid Pharma.
- Headquarter Gurugram, India
- Employees 583 as on 04 Apr, 2024
- Founders Ram Gopal Agarwal
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Dhanuka Laboratories Limited
- Date of Incorporation 24 Feb, 1993
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$132.64 M (USD)-2.3as on Mar 31, 2023
-
Net Profit
$5.33 M (USD)-66.25as on Mar 31, 2023
-
EBITDA
$10.88 M (USD)54.1as on Mar 31, 2023
-
Total Equity Funding
$7.47 M (USD)
in 2 rounds
-
Latest Funding Round
$5.3 M (USD), Unspecified
Mar 27, 2020
-
Investors
Triveni Memorial Educational Trust
& 6 more
-
Employee Count
583
as on Apr 04, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dhanuka Laboratories
Dhanuka Laboratories has successfully raised a total of $7.47M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $5.3 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dhanuka Laboratories
Dhanuka Laboratories has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Triveni Memorial Educational Trust, Manish Dhanuka and Arun Kumar Dhanuka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides comprehensive education solutions for kindergarten and high school students.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
MD
Manish Dhanuka |
-
|
Locked | Locked | Locked |
Investor details for Dhanuka Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dhanuka Laboratories
Dhanuka Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orchid Pharma.
Investment portfolio details for Dhanuka Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bulk actives, formulations, and nutraceuticals are developed and manufactured.
|
Locked | Locked | 1992 | Locked |
Complete acquisition details for Dhanuka Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Dhanuka Laboratories
Detailed financials for Dhanuka Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dhanuka Laboratories Comparisons
Peer comparison for Dhanuka Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dhanuka Laboratories
Detailed competitors of Dhanuka Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dhanuka Laboratories
Complete news archive for Dhanuka Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhanuka Laboratories
Dhanuka Laboratories was founded in 1998 and raised its 1st funding round 21 years after it was founded.
Dhanuka Laboratories is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Dhanuka Laboratories is a funded company, having raised a total of $7.47M across 2 funding rounds to date.
As of Apr 04, 2024, the latest employee count at Dhanuka Laboratories is 583.
Annual revenue of Dhanuka Laboratories is $132.64M as on Mar 31, 2023.
Dhanuka Laboratories was established in 1998 and is based in Gurugram, India. Operations focus on the pharmaceutical sector, where active pharmaceutical ingredients and related products are produced. A variety of oral cephalosporin items, including cefixime (USPEPBPIP), cefuroxime axetil (USPEPBPIP), and cefditoren pivoxil (JPIP), are manufactured and exported to meet international standards.
Dhanuka Laboratories has made 1 acquisition, including Orchid Pharma.
Dhanuka Laboratories has 7 investors. Key investors include Triveni Memorial Educational Trust, Manish Dhanuka, Arun Kumar Dhanuka, Arjun Dhanuka, and Manas Dhanuka.
The valuation of Dhanuka Laboratories is $27.29M as of Mar 2020.